ArticleCancer immunology, immunotherapy : CII2024

Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.

Narendiran Rajasekaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.